Kezar Life Sciences, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Kezar Life Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • Kezar Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$21.5M, a 11.4% increase year-over-year.
  • Kezar Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$98.6M, a 19.4% decline year-over-year.
  • Kezar Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$102M, a 49.3% decline from 2022.
  • Kezar Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$68.2M, a 24.9% decline from 2021.
  • Kezar Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$54.6M, a 30.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$102M -$33.6M -49.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$68.2M -$13.6M -24.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$54.6M -$12.9M -30.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$41.7M -$6.66M -19% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 -$35.1M -$11.9M -51.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 -$23.2M -$14.7M -172% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 -$8.52M +$473K +5.26% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$8.99M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.